Insufficient scRNA-seq data for expression of PYDC2 at single-cell level.
Insufficient scRNA-seq data for expression of PYDC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 14% | 0.24 | 3 / 21 | 1% | 0.02 | 5 / 504 |
adrenal gland | 7% | 0.10 | 17 / 258 | 0% | 0 | 0 / 230 |
lung | 4% | 0.05 | 21 / 578 | 1% | 0.02 | 13 / 1155 |
ovary | 4% | 0.05 | 7 / 180 | 0% | 0.00 | 1 / 430 |
esophagus | 2% | 0.04 | 28 / 1445 | 2% | 0.06 | 3 / 183 |
adipose | 4% | 0.05 | 43 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
blood vessel | 3% | 0.05 | 45 / 1335 | 0% | 0 | 0 / 0 |
spleen | 3% | 0.03 | 8 / 241 | 0% | 0 | 0 / 0 |
breast | 3% | 0.06 | 14 / 459 | 0% | 0.00 | 1 / 1118 |
uterus | 3% | 0.04 | 5 / 170 | 0% | 0 | 0 / 459 |
heart | 3% | 0.04 | 25 / 861 | 0% | 0 | 0 / 0 |
brain | 2% | 0.03 | 62 / 2642 | 0% | 0 | 0 / 705 |
skin | 2% | 0.03 | 33 / 1809 | 0% | 0.01 | 2 / 472 |
stomach | 1% | 0.02 | 5 / 359 | 1% | 0.01 | 2 / 286 |
intestine | 2% | 0.02 | 15 / 966 | 0% | 0.00 | 2 / 527 |
liver | 2% | 0.03 | 4 / 226 | 0% | 0 | 0 / 406 |
peripheral blood | 1% | 0.02 | 12 / 929 | 0% | 0 | 0 / 0 |
kidney | 1% | 0.02 | 1 / 89 | 0% | 0.00 | 1 / 901 |
pancreas | 1% | 0.01 | 2 / 328 | 1% | 0.02 | 1 / 178 |
thymus | 1% | 0.02 | 7 / 653 | 0% | 0 | 0 / 605 |
prostate | 1% | 0.01 | 2 / 245 | 0% | 0.00 | 1 / 502 |
muscle | 1% | 0.02 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0006954 | Biological process | inflammatory response |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_1900226 | Biological process | negative regulation of NLRP3 inflammasome complex assembly |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | PYDC2 |
Protein name | Pyrin domain-containing protein 2 (Pyrin-only protein 2) (cellular POP2) (cPOP2) |
Synonyms | POP2 |
Description | FUNCTION: May play a role in innate immunity by disrupting the interaction between PYCARD and NLRP3, thereby regulating the NLRP3 inflammasome . May also inhibit NF-kappa-B signaling distally by affecting the nuclear accumulation of RELA . . |
Accessions | Q56P42 ENST00000518817.1 |